Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-29 @ 1:38 AM
Study NCT ID:
NCT05361057
Status:
TERMINATED
Last Update Posted:
2025-12-05
First Post:
2022-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-23
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-14
First Submit QC Date:
None
Study First Post Date:
2022-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-28
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED